Amussen Hunsaker & Associates »

Corcept Therapeutics Incorporated shares owned by Amussen Hunsaker & Associates

Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Amussen Hunsaker & Associates from 13F filings

Historical chart of Amussen Hunsaker & Associates investment in Corcept Therapeutics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Corcept Therapeutics Incorporated held by Amussen Hunsaker & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corcept Therapeutics Incorporated by Amussen Hunsaker & Associates

Quarter filed Position value Share count Share price at filing
2025-09-30 $292k 3.5k 83.31
2025-06-30 $257k 3.5k 73.40
2025-03-31 $400k 3.5k 114.22

More positions owned by Amussen Hunsaker & Associates

Berkshire Hathaway Inc Del Cl B New (BRK.B)
Amazon (AMZN)
Meta Platforms Cl A (META)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Alphabet Cap Stk Cl C (GOOG)
American Express Company (AXP)
Microsoft Corporation (MSFT)
Uber Technologies (UBER)
Ishares Tr Ultra Short Dur (ICSH)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Raytheon Technologies Corp (RTX)
Alphabet Cap Stk Cl A (GOOGL)
Netflix (NFLX)

View all positions for Amussen Hunsaker & Associates

Top funds holding Corcept Therapeutics Incorporated

BlackRock
Vanguard Group
Ingalls & Snyder
Renaissance Technologies
Parallel Advisors
State Street Corporation
FMR
Geode Capital Management
Dimensional Fund Advisors
Morgan Stanley
AQR Capital Management
ClearBridge Advisors
Charles Schwab Investment Management
TD Asset Management
Jpmorgan Chase & Co

View all funds holding Corcept Therapeutics Incorporated